ROKU - The Pandemic's Still Not Over: 3 Stay-at-Home Stocks to Buy Right Now
There's excitement in the markets on news that Pfizer 's (NYSE: PFE) coronavirus vaccine is potentially 90% effective in preventing COVID-19. However, Dr. Scott Gottlieb, who previously served as the commissioner of the U.S. Food and Drug Administration, warned people last month not to get too optimistic about a vaccine, telling CNBC in an interview that "we're probably in the seventh inning of the acute phase of this pandemic right now, but the hardest part is probably ahead."
It could be months before people start receiving vaccines, and likely even longer before things start getting back to some sort of normalcy. That's why stay-at-home stocks including GoodRx (NASDAQ: GDRX) , Nintendo (OTC: NTDOY) , and Roku (NASDAQ: ROKU) are still attractive right now: Their products and services will remain in strong demand as people continue sheltering at home and minimizing travel. And many of the new customers those companies gain amid the pandemic will likely stick around even after it's over. Here's a closer look at why they're great buys right now.
California-based GoodRx went public in September, and although its returns thus far haven't been all that impressive -- the stock is down 5% while the S&P 500 has climbed 8% during the same time frame -- that just makes it all the more attractively priced today. The company saves customers (with or without insurance) time and money by finding the best prices on prescriptions, comparing prices from more than 70,000 pharmacies in the process. Patients can easily obtain coupons via email or text message, and thanks to convenient delivery options from many providers, they can use GoodRx to find the cheapest prescriptions without leaving home. .
For further details see:
The Pandemic's Still Not Over: 3 Stay-at-Home Stocks to Buy Right Now